Free Trial
→ INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (From Traders Agency) (Ad)tc pixel Free VRTX Stock Alerts

Vertex Pharmaceuticals (VRTX) SEC Filings & 10K Form

Vertex Pharmaceuticals logo
$391.02 -1.03 (-0.26%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$393.94 +2.92 (+0.75%)
As of 08/29/2025 07:42 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare

Recent Vertex Pharmaceuticals SEC Filings

Export to Excel
DateFilerForm TypeView
08/27/2025
8:38 AM		Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/17/2025
3:09 PM		Upadhyay Suketu (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2025
3:20 PM		McKechnie Duncan (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/19/2025
3:24 PM		Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/15/2025
9:36 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/13/2025
10:32 AM		Capital Research Global Investors (Filed by)
Vertex Pharmaceuticals (Subject)
Form SCHEDULE 13G
05/05/2025
3:52 PM		MCKENZIE DIANA (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:55 PM		SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:57 PM		Schneider Jennifer (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:14 PM		Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:16 PM		CARNEY LLOYD (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/05/2025
3:19 PM		Garber Alan M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/02/2025
8:47 AM		Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/17/2025
3:07 PM		SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2025
3:08 PM		Upadhyay Suketu (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/13/2025
10:10 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/12/2025
3:11 PM		Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/10/2025
12:58 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
12:02 PM		Vertex Pharmaceuticals (Subject)
WAGNER CHARLES F JR (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/10/2025
11:42 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/06/2025
3:08 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/05/2025
3:08 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2025
12:39 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/03/2025
3:17 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/28/2025
3:43 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:46 PM		Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:48 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:31 PM		Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/28/2025
3:36 PM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2025
10:20 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
9:18 AM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/27/2025
9:14 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/26/2025
3:06 PM		Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:07 PM		Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:09 PM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/26/2025
3:11 PM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/25/2025
10:38 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
9:59 AM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/25/2025
10:13 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/24/2025
3:07 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/20/2025
2:45 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
Musk’s Project Colossus could mint millionaires (Ad)

I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.tc pixel

All the details are waiting for you now — but you need to act before the September 1st funding windo
02/19/2025
3:30 PM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:31 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:33 PM		LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/19/2025
3:21 PM		Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/18/2025
10:29 AM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/18/2025
10:34 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/14/2025
3:17 PM		LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
4:14 PM		Vertex Pharmaceuticals (Filer)
Form S-3ASR
02/13/2025
3:53 PM		Capital World Investors (Filed by)
Vertex Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/12/2025
3:46 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:48 PM		Sachdev Amit (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:50 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:52 PM		Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:26 PM		Arbuckle Stuart A (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:21 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
3:24 PM		Ambrose Kristen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/12/2025
8:34 AM		FMR LLC (Filed by)
Vertex Pharmaceuticals (Subject)
Form SCHEDULE 13G/A
02/11/2025
10:57 AM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
10:05 AM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/11/2025
8:49 AM		Atkinson Edward Morrow III (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/06/2025
3:43 PM		Tatsis Ourania (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:45 PM		Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:37 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:38 PM		LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:32 PM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:35 PM		Bozic Carmen (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2025
3:07 PM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2024
2:51 PM		Vertex Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2024
9:31 AM		ALTSHULER DAVID (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/13/2024
3:15 PM		Vertex Pharmaceuticals (Issuer)
WAGNER CHARLES F JR (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
1:58 PM		Kewalramani Reshma (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/05/2024
3:11 PM		Vertex Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/17/2024
3:12 PM		SACHS BRUCE I (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
3:12 PM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/02/2024
9:04 AM		Biller Jonathan (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:47 PM		Bhatia Sangeeta N. (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/30/2024
3:23 PM		LEIDEN JEFFREY M (Reporting)
Vertex Pharmaceuticals (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:VRTX) was last updated on 8/30/2025 by MarketBeat.com Staff
From Our Partners
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
Traders Agency | Sponsoredtc pixel
Everyone’s watching Nvidia right now. Here’s why I’m excited.
So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...
Timothy Sykes | Sponsoredtc pixel
Elon’s Secret Social Security Bombshell
To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...
Banyan Hill Publishing | Sponsoredtc pixel
How “Trump’s New Dollar” Could Impact Your Wealth
President Trump just signed a game-changing law… That could soon upgrade the U.S. dollar in your checking a...
Brownstone Research | Sponsoredtc pixel
Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...
Weiss Ratings | Sponsoredtc pixel
Small Washington, DC Group Could Crash US Stocks
New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split...
Altimetry | Sponsoredtc pixel
BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...
Goldco Precious Metals | Sponsoredtc pixel
My NEXT $1 Trillion Prediction
James Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...
Paradigm Press | Sponsoredtc pixel